1. Bark CJ, Orloff MJ (1972) The partial thromboplastin time and factor VIII therapy. Am J Clin Path 57: 478–481
2. Bartheis M, Poliwoda H (1987) Gerinnungsanalysen. Interpretation, Schnellorientierung. Therapiekontrolle, 3. Aufl. Thieme, Stuttgart New York
3. Köstering H, Kaboth U (1971) Humanes und tierisches AHG in der Notfallbehandlung bei Hämophilie-A-Patienten. In: Deutsch E., Pilgerstorfer HW (Hrsg) Haemophilia. Research, clinical and psycho-social aspects. Schattauer, Stuttgart New York, pp 291–298
4. Mönch H, Köstering H, Schuff-Werner P et al (1986) Hemophilia A, idiopathic thrombocytopenia and HTLV-III-infeetion impressive remission after splenectomy: a case report. Onkologie 9 (4): 239–240
5. Lozier JN, Santagostino E, Kasper CK et al (1993) Use of porcine factor Vili for surgical procedures in hemophilia A patients with inhibitors. Seminars in Hematology (Suppl 1) 30 (2): 10–21